FDA Clearance Tracker · K151545
CardioChek Plus Test System, CardioChek Home Test System, CardioChek PA Test System, CardioChek PA Home Test System
Last checked: Nov 20, 2026Latest source record: Dec 22, 2016 (this decision)Source: openFDAMethods & limitations
Decided
Dec 22, 2016
Substantially Equivalent
Time to decision
562 days
Received Jun 9, 2015. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class I
The decision
- FDA number
- K151545
- Device name
- CardioChek Plus Test System, CardioChek Home Test System, CardioChek PA Test System, CardioChek PA Home Test System
- Applicant
- Polymer Technology Systems, Inc.
- Applicant location
- Indianapolis, IN
- Received
- Jun 9, 2015
- Decided
- Dec 22, 2016
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device class
- Class I
- Regulation
- 21 CFR 862.1175
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code CHH. The earliest in FDA's data is K761263, decided Dec 29, 1976.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K151545
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Polymer Technology Systems, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K193406 · Decided Feb 26, 2022 · 810 days after receipt
Device type: System, Test, Blood Glucose, Over The Counter (NBW) · Laboratory Medicine & Pathology
K182781 · Decided Dec 21, 2018 · 81 days after receipt
Device type: Glucose Oxidase, Glucose (CGA) · Laboratory Medicine & Pathology
K162282 · Decided Dec 22, 2016 · 129 days after receipt
Device type: Glucose Oxidase, Glucose (CGA) · Laboratory Medicine & Pathology
2 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.